Computational study of CCR5 antagonist with support vector machines and three dimensional quantitative structure...

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Virology

Background:

• The C-C chemokine receptor type 5 (CCR5) is a critical co-receptor for the entry of the human immunodeficiency virus type 1 (HIV-1) into host cells.
• CCR5 antagonists represent a key therapeutic strategy for developing novel antiretroviral drugs.
• Previous research has focused on synthesizing and evaluating various CCR5 antagonists.

Purpose of the Study:

• To develop robust predictive models for identifying potent CCR5 antagonists.
• To establish quantitative structure-activity relationships (QSAR) for oximino-piperidino-piperidine derivatives targeting CCR5.
• To compare the predictive performance of different modeling techniques, including support vector machine (SVM) and 3D-QSAR.

Main Methods:

• Utilized non-linear support vector machine (SVM) to model the activity of 103 oximino-piperidino-piperidine CCR5 antagonists.
• Employed comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) after aligning compounds to a common substructure.
• Validated the developed models using a set of 21 structurally diverse compounds not included in the training sets.

Main Results:

• The constructed SVM, CoMFA, and CoMSIA models demonstrated good predictive capabilities, as confirmed by validation with independent compounds.
• Results from SVM and 3D-QSAR models were found to be compatible.
• The 3D-QSAR models significantly outperformed the SVM and previously reported pharmacophore models in predictive accuracy.

Conclusions:

• The developed predictive models offer a valuable tool for quantitative prediction of CCR5 antagonist bioactivity.
• These models can guide the rational design and selection of promising drug candidates, reducing the need for extensive in vitro and in vivo testing.
• The study highlights the superiority of 3D-QSAR approaches over SVM and pharmacophore models for this class of compounds, advancing antiretroviral drug discovery efforts.